Aussie Startup, Japan Pharma Join To Launch First Antiviral Condom
This article was originally published in PharmAsia News
Executive Summary
An Australia startup biotech, Starpharma, is readying for a launch of its first product in Japan later this year when a gel it and Okamoto developed becomes available in a $500 million condom market.